AG Priv.-Doz. Dr. med. Mareike Frick
Sie befinden sich hier:
Focus of research
The research group of Mareike Frick focuses on the investigation of late effects of cancer therapies on a molecular level.
Priv.-Doz. Dr. med. Mareike Frick
Funktionsoberärztin der Klinik
Selected publications
- Feldkamp JD, Vetter VM, Arends CM, ..., Frick M. CHIP-related epigenetic age acceleration correlates with CHIP clone size in patients with high morbidity. Haematologica (2022). doi: 10.3324/haematol.2021.280021 PubMed
- Christen F, Hablesreiter R, Hoyer K, ..., Frick M, Bullinger L, Briest F, Damm F. Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9. Leukemia (2021). doi: 10.1038/s41375-021-01469-x PubMed
- Mylonas E*, Yoshida K*, Frick M*, ..., Damm F. Single-cell analysis based dissection of clonality in myelofibrosis. Nature Communications (2020). doi: 10.1038/s41467-019-13892-x PubMed
- Frick M, Chan W, Arends CM, ..., Damm F. Role of Donor Clonal Hematopoiesis in Allogeneic Hematopoietic Stem-Cell Transplantation. Journal of Clinical Oncology (2019). doi: 10.1200/JCO.2018.79.2184 PubMed
- Arends CM, Galan-Sousa J, Hoyer K, …, Frick M*, Damm F*. Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis. Leukemia (2018). doi:10.1038/s41375-018-0047-7 PubMed
- Frick M, Bettstetter M, Bertz S, ..., Gaumann A. Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL. Leukemia & Lymphoma (2018). doi: 10.1080/10428194.2017.1370546 PubMed
- Rahal R*, Frick M*, Romero R, ..., Stegmeier F. Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphoma. Nature Medicine (2014). doi: 10.1038/nm.3435 PubMed